Abstract
Background
Anastomotic failure (AF) after cytoreductive surgery (CRS) with hyperthermic intraperitoneal chemotherapy (HIPEC) remains a dreaded complication. Whether specific factors, including anastomotic technique, are associated with AF is poorly understood.
Methods
Patients who underwent CRS-HIPEC including at least one bowel resection between 2000 and 2017 from 12 academic institutions were reviewed to determine factors associated with AF (anastomotic leak or enteric fistula).
Results
Among 1020 patients who met the inclusion criteria, the median age was 55 years, 43.9% were male, and the most common histology was appendiceal neoplasm (62.3%). The median Peritoneal Cancer Index was 14, and 93.2% of the patients underwent CC0/1 resection. Overall, 82 of the patients (8%) experienced an AF, whereas 938 (92.0%) did not. In the multivariable analysis, the factors associated with AF included male gender (odds ratio [OR], 2.2; p < 0.01), left-sided colorectal resection (OR 10.0; p = 0.03), and preoperative albumin (OR 1.8 per g/dL; p = 0.02).Technical factors such as method (stapled vs hand-sewn), timing of anastomosis, and chemotherapy regimen used were not associated with AF (all p > 0.05). Anastomotic failure was associated with longer hospital stay (23 vs 10 days; p < 0.01), higher complication rate (90% vs 59%; p < 0.01), higher reoperation rate (41% vs 9%; p < 0.01), more 30-day readmissions (59% vs 22%; p < 0.01), greater 30-day mortality (9% vs 1%; p < 0.01), and greater 90-day mortality (16% vs 8%; p = 0.02) as well as shorter median overall survival (25.6 vs 66.0 months; p < 0.01).
Conclusions
Among patients undergoing CRS-HIPEC, AF is independently associated with postoperative morbidity and worse long-term outcomes. Because patient- and tumor-related, but not technical, factors are associated with AF, operative technique may be individualized based on patient considerations and surgeon preference.
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1245%2Fs10434-019-07964-x/MediaObjects/10434_2019_7964_Fig1_HTML.png)
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1245%2Fs10434-019-07964-x/MediaObjects/10434_2019_7964_Fig2_HTML.png)
Similar content being viewed by others
References
Foster JM, Hall B, Patel A, et al. Morbidity and mortality rates following cytoreductive surgery combined with hyperthermic intraperitoneal chemotherapy compared with other high-risk surgical oncology procedures. JAMA Netw Open. 2019;2:e186847. https://doi.org/10.1001/jamanetworkopen.2018.6847.
Levine EA, Stewart JH, Shen P, Russell GB, Loggie BL, Votanopoulos KI. Intraperitoneal chemotherapy for peritoneal surface malignancy: experience with 1000 patients. J Am Coll Surg. 2014;218:573–85. https://doi.org/10.1016/j.jamcollsurg.2013.12.013.
Younan R, Kusamura S, Baratti D, et al. Bowel complications in 203 cases of peritoneal surface malignancies treated with peritonectomy and closed-technique intraperitoneal hyperthermic perfusion. Ann Surg Oncol. 2005;12:910–18. https://doi.org/10.1245/aso.2005.11.030.
Elias D, Gilly F, Boutitie F, et al. Peritoneal colorectal carcinomatosis treated with surgery and perioperative intraperitoneal chemotherapy: retrospective analysis of 523 patients from a multicentric French study from the Institut. J Clin Oncol. 2009;28:63–8. https://doi.org/10.1200/jco.2009.23.9285.
Glehen O, Gilly FN, Boutitie F, et al. Toward curative treatment of peritoneal carcinomatosis from nonovarian origin by cytoreductive surgery combined with perioperative intraperitoneal chemotherapy. Cancer. 2010;116:5608–18. https://doi.org/10.1002/cncr.25356.
Chouliaras K, Levine EA, Fino N, Shen P, Votanopoulos KI. Prognostic factors and significance of gastrointestinal leak after cytoreductive surgery (CRS) with heated intraperitoneal chemotherapy (HIPEC). Ann Surg Oncol. 2017;24:890–7. https://doi.org/10.1245/s10434-016-5738-6.
Quenet F, Elias D, Roca L, et al. A UNICANCER phase III trial of hyperthermic intra-peritoneal chemotherapy (HIPEC) for colorectal peritoneal carcinomatosis (PC): PRODIGE 7. J Clin Oncol. 2018;36:1. https://doi.org/10.1200/jco.2018.36.18_suppl.lba3503.
Jaehne J. Cytoreductive procedures: strategies to reduce postoperative morbidity and management of surgical complications with special emphasis on anastomotic leaks. J Surg Oncol. 2009;100:302–5. https://doi.org/10.1002/jso.21328.
Desantis M, Bernard JL, Casanova V, et al. Morbidity, mortality, and oncological outcomes of 401 consecutive cytoreductive procedures with hyperthermic intraperitoneal chemotherapy (HIPEC). Langenbeck’s Arch Surg. 2015;400:37–48. https://doi.org/10.1007/s00423-014-1253-z.
Dodson RM, Kuncewitch M, Votanopoulos KI, Shen P, Levine EA. Techniques for cytoreductive surgery with hyperthermic intraperitoneal chemotherapy. Ann Surg Oncol. 2018;25:2152–8. https://doi.org/10.1245/s10434-018-6336-6.
Canda AE, Sokmen S, Terzi C, et al. Complications and toxicities after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. Ann Surg Oncol. 2013;20:1082–7. https://doi.org/10.1245/s10434-012-2853-x.
Jacquet P, Sugarbaker PH. Clinical research methodologies in diagnosis and staging of patients with peritoneal carcinomatosis. Cancer Treat Res. 1996;82:359–74.
Harmon RL, Sugarbaker PH. Prognostic indicators in peritoneal carcinomatosis from gastrointestinal cancer. Int Semin Surg Oncol. 2005;2:1–10. https://doi.org/10.1186/1477-7800-2-3.
Clavien PA, Barkun J, de Oliveira ML, et al. The Clavien-Dindo classification of surgical complications: five-year experience. Ann Surg. 2009;250:187–96. https://doi.org/10.1097/sla.0b013e3181b13ca2.
Turrentine FE, Denlinger CE, Simpson VB, et al. Morbidity, mortality, cost, and survival estimates of gastrointestinal anastomotic leaks. J Am Coll Surg. 2015;220:195–206. https://doi.org/10.1016/j.jamcollsurg.2014.11.002.
La Regina D, Di Giuseppe M, Lucchelli M, et al. Financial impact of anastomotic leakage in colorectal surgery. J Gastrointest Surg. 2019;23:580–6. https://doi.org/10.1007/s11605-018-3954-z.
Glockzin G, Schlitt HJ, Piso P. Peritoneal carcinomatosis: patients selection, perioperative complications, and quality of life related to cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. World J Surg Oncol. 2009;7:1–8. https://doi.org/10.1186/1477-7819-7-5.
Goto S, Hasegawa S, Hida K, et al. Multicenter analysis of impact of anastomotic leakage on long-term oncologic outcomes after curative resection of colon cancer. Surg United States. 2017;162:317–24. https://doi.org/10.1016/j.surg.2017.03.005.
Sciuto A, Merola G, De Palma GD, et al. Predictive factors for anastomotic leakage after laparoscopic colorectal surgery. World J Gastroenterol. 2018;24:2247–60. https://doi.org/10.3748/wjg.v24.i21.2247.
Blouhos K, Pramateftakis M-G, Tsachalis T, et al. The integrity of colonic anastomoses following the intraperitoneal administration of oxaliplatin. Int J Colorectal Dis. 2010;25:835–41. https://doi.org/10.1007/s00384-010-0912-y.
Pelz JOW, Doerfer J, Decker M, Dimmler A, Hohenberger W, Meyer T. Hyperthermic intraperitoneal chemoperfusion (HIPEC) decrease wound strength of colonic anastomosis in a rat model. Int J Colorectal Dis. 2007;22:941–7. https://doi.org/10.1007/s00384-006-0246-y.
Quenet F, Elias D, Roca L, et al. A UNICANCER phase III trial of hyperthermic intraperitoneal chemotherapy (HIPEC) for colorectal peritoneal carcinomatosis. Retrieved 25 August 2019 at https://psmo.org.ph/wp-content/uploads/2019/04/Colorectal-Cancer-Abstract-Presentation-B.pdf. Published 2018..
Van Driel WJ, Koole SN, Sikorska K, et al. Hyperthermic intraperitoneal chemotherapy in ovarian cancer. Obstet Gynecol Surv. 2018;73:280–1. https://doi.org/10.1097/01.ogx.0000532155.55081.57.
Park JS, Huh JW, Park YA, et al. Risk factors of anastomotic leakage and long-term survival after colorectal surgery. Med United States. 2016;95:1–10. https://doi.org/10.1097/md.0000000000002890.
Lipska MA, Bissett IP, Parry BR, Merrie AEH. Anastomotic leakage after lower gastrointestinal anastomosis: men are at a higher risk. ANZ J Surg. 2006;76:579–85. https://doi.org/10.1111/j.1445-2197.2006.03780.x.
Ba ZF, Bland KI, Rue LW, Chaudry IH, Yokoyama Y, Toth B. Gender differences in small intestinal endothelial function: inhibitory role of androgens. Am J Physiol Liver Physiol. 2004;286:G452–7. https://doi.org/10.1152/ajpgi.00357.2003.
Telem DA, Chin EH, Nguyen SQ, Divino CM. Risk factors for anastomotic leak following colorectal surgery: a case-control study. Arch Surg. 2010;145:371–6. https://doi.org/10.1001/archsurg.2010.40.
Warschkow R, Steffen T, Thierbach J, Bruckner T, Lange J, Tarantino I. Risk factors for anastomotic leakage after rectal cancer resection and reconstruction with colorectostomy. a retrospective study with bootstrap analysis. Ann Surg Oncol. 2011;18:2772–82. https://doi.org/10.1245/s10434-011-1696-1.
Aloia TA, Fahy BN, Fischer CP, et al. Predicting poor outcome following hepatectomy: analysis of 2313 hepatectomies in the NSQIP database. HPB. 2009;11:510–15. https://doi.org/10.1111/j.1477-2574.2009.00095.x.
Greenblatt DY, Kelly KJ, Rajamanickam V, et al. Preoperative factors predict perioperative morbidity and mortality after pancreaticoduodenectomy. Ann Surg Oncol. 2011;18:2126–35. https://doi.org/10.1245/s10434-011-1594-6.
Bartlett EK, Meise C, Roses RE, Fraker DL, Kelz RR, Karakousis GC. Morbidity and mortality of cytoreduction with intraperitoneal chemotherapy: outcomes from the ACS NSQIP database. Ann Surg Oncol. 2014;21:1494–500. https://doi.org/10.1245/s10434-013-3223-z.
Franko J, Gusani NJ, Holtzman MP, et al. Multivisceral resection does not affect morbidity and survival after cytoreductive surgery and chemoperfusion for carcinomatosis from colorectal cancer. Ann Surg Oncol. 2008;15:3065–72. https://doi.org/10.1245/s10434-008-0105-x.
Roviello F, Marrelli D, Neri A, et al. Treatment of peritoneal carcinomatosis by cytoreductive surgery and intraperitoneal hyperthermic chemoperfusion (IHCP): postoperative outcome and risk factors for morbidity. World J Surg. 2006;30:2033–40. https://doi.org/10.1007/s00268-006-0038-0.
Kiran RP, Murray ACA, Chiuzan C, Estrada D, Forde K. Combined preoperative mechanical bowel preparation with oral antibiotics significantly reduces surgical-site infection, anastomotic leak, and ileus after colorectal surgery. Ann Surg. 2015;262:416–23. https://doi.org/10.1097/sla.0000000000001416.
Ahmed J, Khan S, Lim M, Chandrasekaran T V., Macfie J. Enhanced recovery after surgery protocols: compliance and variations in practice during routine colorectal surgery. Color Dis. 2012;14:1045–51. https://doi.org/10.1111/j.1463-1318.2011.02856.x.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Disclosure
There are no conflicts of interest.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Wiseman, J.T., Kimbrough, C., Beal, E.W. et al. Predictors of Anastomotic Failure After Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy: Does Technique Matter?. Ann Surg Oncol 27, 783–792 (2020). https://doi.org/10.1245/s10434-019-07964-x
Received:
Published:
Issue Date:
DOI: https://doi.org/10.1245/s10434-019-07964-x